Authors: VANGILS FCJM VANTEEFFELEN MEJM NEELIS KJ HENDRIKX J BURGER H VANLEEN RW KNOL E WAGEMAKER G WOGNUM AW

Citation: Fcjm. Vangils et al., INTERLEUKIN-3 TREATMENT OF RHESUS-MONKEYS LEADS TO INCREASED PRODUCTION OF HISTAMINE-RELEASING CELLS THAT EXPRESS INTERLEUKIN-3 RECEPTORS AT HIGH-LEVELS, Blood, 86(2), 1995, pp. 592-597

Authors: VANGILS FCJM WESTERMAN Y VISSER TP BURGER H VANLEEN RW WAGEMAKER G

Citation: Fcjm. Vangils et al., NEUTRALIZING ANTIBODIES DURING TREATMENT OF HOMOLOGOUS NONGLYCOSYLATED IL-3 IN RHESUS-MONKEYS, Leukemia, 8(4), 1994, pp. 648-651

Authors: VANGILS FCJM BUDEL LM BURGER H VANLEEN RW LOWENBERG B WAGEMAKER G

Citation: Fcjm. Vangils et al., INTERLEUKIN-3 (IL-3) RECEPTORS ON RHESUS-MONKEY BONE-MARROW CELLS - SPECIES-SPECIFICITY OF HUMAN IL-3, BINDING CHARACTERISTICS, AND LACK OFCOMPETITION WITH GM-CSF, Experimental hematology, 22(3), 1994, pp. 248-255

Authors: VANGILS FCJM WESTERMAN Y VANDENBOS C BURGER H VANLEEN RW WAGEMAKER G

Citation: Fcjm. Vangils et al., PHARMACOKINETIC BASIS FOR OPTIMAL HEMATOPOIETIC EFFECTIVENESS OF HOMOLOGOUS IL-3 ADMINISTERED TO RHESUS-MONKEYS, Leukemia, 7(10), 1993, pp. 1602-1607

Authors: MERTENS K DONATH MJS VANLEEN RW DEKEYZERNELLEN MJM VERBEET MP BOS JMK LEYTE A VANMOURIK JA

Citation: K. Mertens et al., BIOLOGICAL-ACTIVITY OF RECOMBINANT FACTOR-VIII VARIANTS LACKING THE CENTRAL B-DOMAIN AND THE HEAVY-CHAIN SEQUENCE LYS713-ARG740 - DISCORDANT IN-VITRO AND IN-VIVO ACTIVITY, British Journal of Haematology, 85(1), 1993, pp. 133-142

Authors: VANGILS FCJM MULDER AH VANDENBOS C BURGER H VANLEEN RW WAGEMAKER G

Citation: Fcjm. Vangils et al., ACUTE SIDE-EFFECTS OF HOMOLOGOUS INTERLEUKIN-3 IN RHESUS-MONKEYS, The American journal of pathology, 143(6), 1993, pp. 1621-1633